AAAAAA
Results:
1-7
|
Results: 7
Authors:
Gyonos, I
Agoston, M
Kovacs, A
Szenasi, G
Vereckei, A
Citation: I. Gyonos et al., Silymarin and vitamin E do not attenuate and vitamin E might even enhance the antiarrhythmic activity of amiodarone in a rat reperfusion arrhythmia model, CARDIO DRUG, 15(3), 2001, pp. 233-240
Authors:
Kovacs, A
Gyonos, I
Magyar, J
Banyasz, T
Nanasi, PP
Spedding, M
Szenasi, G
Citation: A. Kovacs et al., Effects of EGIS-7229 (S 21407), a novel class III antiarrhythmic drug, on myocardial refractoriness to electrical stimulation in vivo and in vitro, J CARDIO PH, 37(1), 2001, pp. 78-88
Authors:
Magyar, J
Banyasz, T
Fulop, L
Szentandrassy, N
Kortvely, A
Kovacs, A
Szenasi, G
Nanasi, PP
Citation: J. Magyar et al., Effects of the antiarrhythmic agent EGIS-7229 (S 21407) on calcium and potassium currents in canine ventricular cardiomyocytes, N-S ARCH PH, 363(6), 2001, pp. 604-611
Authors:
Sterczer, A
Szenasi, G
Voros, K
Pap, A
Citation: A. Sterczer et al., Effects of lorglumide and atropine on MgSO4-induced gallbladder emptying in conscious dogs, RES VET SCI, 69(2), 2000, pp. 129-133
Authors:
Detari, L
Szentgyorgyi, V
Hajnik, T
Szenasi, G
Gacsalyi, I
Kukorelli, T
Citation: L. Detari et al., Differential EEG effects of the anxiolytic drugs, deramciclane (EGIS-3886), ritanserin and chlordiazepoxide in rats, PSYCHOPHAR, 142(3), 1999, pp. 318-326
Authors:
Banyasz, T
Magyar, J
Varro, A
Kovacs, A
Gyonos, I
Szenasi, G
Nanasi, PP
Citation: T. Banyasz et al., EGIS-7229, the new combined class III antiarrhythmic agent - Lack of EAD inducing effect, GEN PHARM, 32(3), 1999, pp. 329-333
Authors:
Varga, G
Kordas, K
Burghardt, B
Gacsalyi, I
Szenasi, G
Citation: G. Varga et al., Effect of deramciclane, a new 5-HT receptor antagonist, on cholecystokinin-induced changes in rat gastrointestinal function, EUR J PHARM, 367(2-3), 1999, pp. 315-323
Risultati:
1-7
|